TO COMPARE THE RESULT OF TWO MEDICINE ON PIMPLES

A comparative evaluation of topical Clindamycin 1% gel and Ozenoxacin 2% lotion in Acne Vulgaris: A randomized control trial - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059911

Enrollment

Registered

2023-11-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: topical clindamycin 1% gel: TO BE APPLIED TOPICALLY ON ACNE Control Intervention1: topical ozenoxacin 2% lotion: TO BE APPLIED TOPICALLY ON ACNE

Eligibility

Inclusion criteria

Inclusion criteria: Patient with age group of 18 to 35 years,Acne Grade II and Grade III,Patients who were not taking any systemic antibiotic or retinoid for last two months or using topical treatments of acne for last one month.

Exclusion criteria

Exclusion criteria: Patients having comedones grade I and nodulocystic acne grade IV, Acne conglobata, Acne fulmicans and secondary acne,Pregnant and lactating women,A known case of drug hypersensitivity,Patients on steroids and antibiotics for any other condition,Female patients who are on oral contraceptives.

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of topical ozenoxacin 2% lotion in acne vulgaris (Grade II, III). •To evaluate the efficacy of topical clindamycin 1% gel in acne vulgaris (Grade II, III).Timepoint: DAY 0,2 WEEKS,4 WEEKS AND 6 WEEKS	—

Secondary

Measure	Time frame
To compare the efficacy of clindamycin and ozenoxacin in acne vulgaris.Timepoint: DAY 0,2 WEEKS,4 WEEKS AND 6 WEEKS	—

Countries

India

Contacts

Public ContactSupriya Agarwal

ROHILKHAND MEDICAL COLLEGE

drpraveenderma@gmail.com09412332063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026